Dipeptidyl peptidase IV, which probably plays important roles in Alzheimer disease (AD) pathology, is upregulated in AD brain neurons and associates with amyloid plaques

Neurochemistry International

Volumn 114, Issue , 2018, Pages 55-57

  Bernstein, Hans Gert ^a   Dobrowolny, Henrik ^a   Keilhoff, Gerburg ^a   Steiner, Johann ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Alzheimer's disease; Amyloid; DPP IV; Immunohistochemistry; Neurons

Indexed keywords

CONGO RED; DIPEPTIDYL PEPTIDASE IV; MONOCLONAL ANTIBODY ALZ 50; DIPEPTIDYL PEPTIDASE IV INHIBITOR; DPP4 PROTEIN, HUMAN;

AGED; ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTICLE; AUTOPSY; BRAIN CELL; BRAIN NERVE CELL; CINGULATE GYRUS; COGNITION; CONTROLLED STUDY; DSM-IV; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; MALE; MENTAL DETERIORATION; MINI MENTAL STATE EXAMINATION; PATHOLOGY; POSTERIOR CINGULATE; PRIORITY JOURNAL; SILVER STAINING; TEMPORAL CORTEX; UPREGULATION; ANIMAL; BIOSYNTHESIS; BRAIN; DRUG EFFECT; ENZYMOLOGY; NERVE CELL; PHYSIOLOGY;

ALZHEIMER DISEASE; ANIMALS; BRAIN; DIPEPTIDYL PEPTIDASE 4; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; HUMANS; NEURONS; PLAQUE, AMYLOID; UP-REGULATION;

EID: 85040649032     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2018.01.005     Document Type: Article

References (20)

1. Antonyan, A., Schlenzig, D., Schilling, S., Naumann, M., Sharoyan, S., Demuth, S.H.U., Dec 7. Mardanyan Concerted action of dipeptidyl peptidase IV and glutaminyl cyclase results in formation of pyroglutamate-modified amyloid peptides in vitro. Neurochem. Int. 113, 112–119. https://doi.org.10.1016/j.neuint.2017.12.001.
2. Aoyagi, T., Wada, T., Kojima, F., Nagai, M., Harada, S., Takeuchi, T., Isse, K., Ogura, M., Hamamoto, M., Tanaka, K., Nagao, T., Enzymatic changes in cerebrospinal fluid of patients with Alzheimer-type dementia. J. Clin. Biochem. Nutr. 14 (1993), 133–139.
3. Bassil, F., Fernagut, P.O., bezard, E., Meissner, W.G., Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification?. Prog. Neurobiol. 118 (2014), 1–18.
4. Bernstein, H.G., Schön, E., Ansorge, S., Röse, I., Dorn, A., Immunolocalization of dipeptidyl aminopeptidase (DAP IV) in the developing human brain. Int. J. Dev. Neurosci. 5 (1987), 237–242.
5. Bernstein, H.-G., Ansorge, S., Riederer, P., Reiser, M., Frohlich, L., Bogerts, B., Insulin-degrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques. Neurosci. Lett. 263 (1999), 161–164.
6. D'Amico, M., Di Filippo, C., Marfella, R., Abbatecola, A.M., Ferraraccio, F., Rossi, F., Paolisso, G., Long-term inhibition of dipeptidyl peptidase-4 in Alzheimer's prone mice. Exp. Gerontol. 45 (2010), 202–207.
7. Hartlage-Rübsamen, M., Morawski, M., Waniek, A., Jäger, C., Zeitschel, U., Koch, B., Cynis, H., Schilling, S., Schliebs, R., Demuth, H.U., Rossner, S., Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-Aβ deposits in hippocampus via distinct cellular mechanisms. Acta Neuropathol. 121 (2011), 705–719.
8. Hook, G., Yu, J., Toneff, T., Kindy, M., Hook, V., Brain pyroglutamate amyloid-β is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer's disease therapeutic. J. Alzheim. Dis. 41 (2014), 129–149.
9. Isik, A.T., Soysal, P., Yay, A., Usrael, C., The effects of sitapliptin, a DPP-4 inhibitor, on cognitive functions in elderly diabetic patients with or without Alzheimer's disease. Diabetes Res. Clin. Pract. 123 (2017), 192–198.
10. Kim, D.H., Huh, J.W., Jang, M., Suh, J.H., Kim, T.W., Park, J.S., Yoon, S.Y., Sitagliptin increases tau phosphorylation in the hippocampus of rats with type 2 diabetes and primary neurons cultures. Neurobiol. Dis. 46 (2012), 52–58.
11. Kornelius, E., Lin, C.L., Chang, H.H., Li, H.H., Huang, W.N., Yang, Y.S., Lu, Y.L., Peng, C.H., Huang, C.N., DPP-4 inhibitor linagliptin attenuates Aβ –induced cytotoxicity through activation of AMPK in neuronal cells. CNS Neurosci. Ther. 21 (2015), 549–557.
12. Kosaraju, J., Murthy, V., Khatwal, R.B., Dubala, A., Chinni, S., Muthureddi Nataraj, S.K., Basavan, D., Vildagliptin: an anti-diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin-induced Alzheimer's disease. J. Pharm. Pharmacol. 65 (2013), 1773–1784.
13. Kosaraju, J., Madhunapantula, S.V., Chinni, S., Khatwal, R.B., Dubala, A., Chinni, S., Muthureddi Nataraj, S.K., Basavan, D., Dipeptidyl peptidase-4 inhibition by Pterocarpus marsupium and Eugenia jambolana ameliorates streptozotocin induced Alzheimer's disease. Behav. Brain Res. 267 (2014), 55–65.
14. Lomabardi, V.R., Garcia, M., Rey, L., Cacabelos, R., Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's disease (AD) individuals. J. Neuroimmunol. 97 (1999), 163–171.
15. Matteucci, E., Giampietro, O., Mechanisms of neurodegeneration in type 2 diabetes and the neuroprotective potential of dipeptidyl peptidase 4 inhibitors. Curr. Med. Chem. 22 (2015), 1573–1581.
16. Mirra, S.S., Heyman, A., McKeel, D., Sumi, S., Crain, B.J., Brownlee, L.M., Vogel, F.S., Hughes, J.P., van Belle, G., Berg, L., 1991. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathological assessment of Alzheimer's disease Neurology. 41, pp. 479–486.
17. Movisisyan, N.N., Sharoyan, S.G., Antonian, A.A., Mardayan, S.S., Breakdown of some neuronal peptides with dipeptidyl peptidase IV. Proc. Yerevan State Univ. 1 (2013), 36–39.
18. Nazarova, G.A., Kolyasnikova, K.N., Zolotov, N.N., Changes in activity of proline-specific peptidase in rat model for dementia of Alzheimer's type. Bull. Exp. Biol. Med. 153 (2012), 674–676.
19. Sharoyan, S., Antonyan, A., Mardayan, S., Harutuyan, H., Movisisyan, N., Hovanyan, K., Interaction of dipeptidyl peptidase IV with amyloid peptides. Neurochem. Int. 62 (2013), 1048–1054.
20. Spiechowicz, M., Bernstein, H.G., Dobrowolny, H., Leśniak, W., Mawrin, C., Bogerts, B., Kuźnicki, J., Filipek, A., Density of Sgt1-immunopositive neurons is decreased in the cerebral cortex of Alzheimer's disease brain. Neurochem. Int. 49 (2006), 487–493.